$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Cholesterol lowering method of use 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/35
  • A61K-031/355
  • C07D-311/04
  • C07D-311/74
  • C07D-311/76
출원번호 US-0616478 (1984-06-01)
발명자 / 주소
  • Burger Warren C. (Mt. Horeb WI) Qureshi Asaf A. (Madison WI) Elson Charles E. (Madison WI)
출원인 / 주소
  • Wisconsin Alumni Research Foundation (Madison WI 02)
인용정보 피인용 횟수 : 45  인용 특허 : 5

초록

A method of lowering cholesterol comprises administering to an animal safe and effective amounts of d-aaa

대표청구항

The method of lowering blood cholesterol levels in an animal in need of a lowered cholesterol which comprises administering to said animal a safe and effective amount of a compound of the following formula: [Figure] in which R and R1 are lower alkyls of 1 to 4 carbon atoms.

이 특허에 인용된 특허 (5)

  1. Hoefle Milton L. (Ann Arbor MI), 2,2-Dimethyl-5-(2,5-dimethylphenoxy)pentyl ester of 3-pyridine carboxylic acid and use as an anti-atherosclerotic agent.
  2. Sircar Ila (Ann Arbor MI), Anti-arteriosclerotic agents.
  3. Mattson Fred Hugh (Cincinnati OH), Compositions for inhibiting absorption of cholesterol.
  4. Igarashi ; Toshiji ; Ohtake ; Shinzaburo, Method for the treatment of hypertension.
  5. Woziwodzki ; Hiltrud E., Separation of the isomers of tocopherol by liquid/solid chromatography.

이 특허를 인용한 특허 (45)

  1. West, Simon Michael; Ogru, Esra; Gianello, Robert, Alkaloid formulations.
  2. Berry Christopher J.,THX ; Bierenbaum Marvin L., Anticholesterolemic edible oil.
  3. West, Simon Michael; Kannar, David, Carrier.
  4. Libinaki, Roksan, Carrier comprising non-neutralised tocopheryl phosphate.
  5. Gavin, Paul; Gianello, Robert; Ogru, Esra, Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof.
  6. Libinaki, Roksan, Composition.
  7. Elkin Robert G. ; Yan Zhihong, Composition and method for producing low cholesterol eggs.
  8. Libinaki, Roksan, Composition comprising non-neutralised tocol phosphate and a vitamin A compound.
  9. Guthrie, Najla, Compositions and methods for glycemic control of subjects with impaired fasting glucose.
  10. Guthrie, Najla, Compositions and methods for glycemic control of subjects with impaired fasting glucose.
  11. Guthrie Najla,CAX ; Kurowska Elzbieta Maria,CAX, Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols.
  12. Nawar, Wassef W., Cranberry seed oil extract and compositions containing components thereof.
  13. Nawar, Wassef W., Cranberry seed oil extract and compositions containing components thereof.
  14. Nawar, Wassef W., Cranberry seed oil extract and compositions containing components thereof.
  15. West, Simon Michael; Verdicchio, Robert J.; Kannar, David; Mills, Jr., Otto H., Dermal therapy using phosphate derivatives of electron transfer agents.
  16. Cook Mark E. ; Pariza Michael W., Dietetic foods containing conjugated linoleic acids.
  17. Cook Mark E. ; Aydin Rahim ; Pariza Michael W., Eggs enriched with conjugated linoleic acid.
  18. West, Simon Michael, Formulation containing phosphate derivatives of electron transfer agents.
  19. Kramer Klaus,DEX ; Baldenius Kai-Uwe,DEX ; Hoppe Peter Paul,DEX, Inhibitors of cholesterol-biosynthesis for reducing the cholesterol content of poultry eggs.
  20. Cefali, Eugenio A.; Bova, David J., Intermediate release nicotinic acid compositions for treating hyperlipidemia.
  21. Cefali, Eugenio A., Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics.
  22. Reich John J. (3N 550 Crown Rd. Elmhurst IL 60126), Method for prevention and treatment of hyperchlolesterolemia by in vivo hydrogenation of cholesterol.
  23. Cook Mark E. (Madison WI) Pariza Michael W. (Madison WI) Park Yeonhwa (Madison WI), Method for reducing body fat in animals.
  24. Beitz Donald C. (Ames IA) Young Jerry W. (Ames IA) Dehal Shangara S. (Ames IA), Method of converting cholesterol in food to coprostanol.
  25. Cook Mark E ; Jerome Daria L ; Pariza Michael W ; Buege Dennis R ; Mozdziak Paul, Method of increasing fat firmness and improving meat quality in animals.
  26. Cook Mark E. ; Jerome Daria L. ; Pariza Michael W. ; Buege Dennis R., Method of increasing fat firmness and improving meat quality in animals with conjugated linolenic acid.
  27. Pariza Michael W. ; Yang Xiao-Yun, Method of producing conjugated fatty acids.
  28. Bova David J., Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night.
  29. Cefali, Eugenio A.; Bova, David J., Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia.
  30. Cook Mark E. (Madison WI) Cook Ellen B. (Madison WI) Stahl James L. (Madison WI) Graziano Frank M. (Oregon WI) Pariza Michael W. (Madison WI), Methods of attenuating the allergic response in animals.
  31. Cook Mark E. ; Kim Sohee,KRX ; Pariza Michael W. ; DeVoney Danielle, Methods of treating animals to enhance natural killer lymphocyte function.
  32. Cook Mark E. (Madison WI) Pariza Michael W. (Madison WI) Yang Xiaoyun (Madison WI) DeVoney Danielle (Madison WI), Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations.
  33. Pariza Michael W. ; Yang Xiaoyun, Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations.
  34. Bova David J., Nicotinic acid compositions for treating hyperlipidemia and related methods therefor.
  35. Bova, David J, Nicotinic acid compositions for treating hyperlipidemia and related methods therefor.
  36. Beitz Donald C. ; Young Jerry W. ; Li Ling ; Buhman Kimberly K., Oral administration of coprostanol producing microorganisms to humans to decrease plasma cholesterol concentration.
  37. Wesson, Kieron W.; Hinman, Andrew W.; Jankowski, Orion D., Process for the production of alpha-tocotrienol and derivatives.
  38. Jacobs, Lewis, Process for the production of tocotrienols.
  39. Zima,George Chester; Oldfield,Terry Ann; Dobbs,Suzanne Winegar; Cook,Phillip Michael; Kelly,Charles Everette; Crow,Mary Caraway; Hoyme,Craig Alan, Process for the recovery of a phytolipid composition.
  40. Zima,George Chester; Oldfield,Terry Ann; Dobbs,Suzanne Winegar; Cook,Phillip Michael; Kelly,Charles Everette; Crow,Mary Caraway; Hoyme,Craig Alan, Process for the recovery of a phytolipid composition.
  41. Howard, Luke, Process of producing purified gamma- and delta-tocotrienols from tocol-rich oils or distillates.
  42. Lane Ronald H. ; Becker Kenneth W. ; Qureshi Asaf A. ; Wells D. Michael, Processes for recovering tocotrienols, tocopherols and tocotrienol-like compounds.
  43. Barrie Tan ; John Foley, Tocotrienols and geranylgeraniol from Bixa orellana byproducts.
  44. Cottrell, Jeremy; Gaetano, Giacinto; El-Tamimy, Mahmoud; Kennedy, Nicholas; Gavin, Paul David, Transdermal delivery patch.
  45. Cottrell, Jeremy; Gaetano, Giacinto; El-Tamimy, Mahmoud; Kennedy, Nicholas; Gavin, Paul David, Transdermal delivery patch.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로